Basso Stephen 4
4 · Inozyme Pharma, Inc. · Filed Jan 14, 2021
Insider Transaction Report
Form 4
Basso Stephen
Senior Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2021-01-13+41,794→ 41,794 totalExercise: $2.77Exp: 2030-04-22→ Common Stock (41,794 underlying)
Footnotes (1)
- [F1]This option was granted on April 23, 2020, with vesting subject to the satisfaction of performance based vesting criteria. The performance based vesting criteria were satisfied on January 13, 2021 and the shares underlying the option vest in equal monthly installments from April 23, 2020 through April 23, 2024.